Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > UBR1(Gene name) > Human
  • Add your favorite
  • UBR1 (Gene name),
  • E3 ubiquitin-protein ligase UBR1 (Protein name ),  UBR1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    UBR1;
    Protein name:
    E3 ubiquitin-protein ligase UBR1;
    Alternative:
    Ubiquitin-protein ligase E3-alpha-1;N-recognin-1;Ubiquitin-protein ligase E3-alpha-I;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with RECQL4.
    Function:
    E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. May be involved in pancreatic homeostasis. Binds leucine and is a negative regulator of the leucine-mTOR signaling pathway, thereby controlling cell growth.
    Subcellular Location:
    Cytoplasm cytosol
    Protein Attributes:
    Sequence length:
    1749
    Sequence:
    50:
    MADEEAGGTE | RMEISAELPQ | TPQRLASWWD | QQVDFYTAFL | HHLAQLVPEI | 
    100:
    YFAEMDPDLE | KQEESVQMSI | FTPLEWYLFG | EDPDICLEKL | KHSGAFQLCG | 
    150:
    RVFKSGETTY | SCRDCAIDPT | CVLCMDCFQD | SVHKNHRYKM | HTSTGGGFCD | 
    200:
    CGDTEAWKTG | PFCVNHEPGR | AGTIKENSRC | PLNEEVIVQA | RKIFPSVIKY | 
    250:
    VVEMTIWEEE | KELPPELQIR | EKNERYYCVL | FNDEHHSYDH | VIYSLQRALD | 
    300:
    CELAEAQLHT | TAIDKEGRRA | VKAGAYAACQ | EAKEDIKSHS | ENVSQHPLHV | 
    350:
    EVLHSEIMAH | QKFALRLGSW | MNKIMSYSSD | FRQIFCQACL | REEPDSENPC | 
    400:
    LISRLMLWDA | KLYKGARKIL | HELIFSSFFM | EMEYKKLFAM | EFVKYYKQLQ | 
    450:
    KEYISDDHDR | SISITALSVQ | MFTVPTLARH | LIEEQNVISV | ITETLLEVLP | 
    500:
    EYLDRNNKFN | FQGYSQDKLG | RVYAVICDLK | YILISKPTIW | TERLRMQFLE | 
    550:
    GFRSFLKILT | CMQGMEEIRR | QVGQHIEVDP | DWEAAIAIQM | QLKNILLMFQ | 
    600:
    EWCACDEELL | LVAYKECHKA | VMRCSTSFIS | SSKTVVQSCG | HSLETKSYRV | 
    650:
    SEDLVSIHLP | LSRTLAGLHV | RLSRLGAVSR | LHEFVSFEDF | QVEVLVEYPL | 
    700:
    RCLVLVAQVV | AEMWRRNGLS | LISQVFYYQD | VKCREEMYDK | DIIMLQIGAS | 
    750:
    LMDPNKFLLL | VLQRYELAEA | FNKTISTKDQ | DLIKQYNTLI | EEMLQVLIYI | 
    800:
    VGERYVPGVG | NVTKEEVTMR | EIIHLLCIEP | MPHSAIAKNL | PENENNETGL | 
    850:
    ENVINKVATF | KKPGVSGHGV | YELKDESLKD | FNMYFYHYSK | TQHSKAEHMQ | 
    900:
    KKRRKQENKD | EALPPPPPPE | FCPAFSKVIN | LLNCDIMMYI | LRTVFERAID | 
    950:
    TDSNLWTEGM | LQMAFHILAL | GLLEEKQQLQ | KAPEEEVTFD | FYHKASRLGS | 
    1000:
    SAMNIQMLLE | KLKGIPQLEG | QKDMITWILQ | MFDTVKRLRE | KSCLIVATTS | 
    1050:
    GSESIKNDEI | THDKEKAERK | RKAEAARLHR | QKIMAQMSAL | QKNFIETHKL | 
    1100:
    MYDNTSEMPG | KEDSIMEEES | TPAVSDYSRI | ALGPKRGPSV | TEKEVLTCIL | 
    1150:
    CQEEQEVKIE | NNAMVLSACV | QKSTALTQHR | GKPIELSGEA | LDPLFMDPDL | 
    1200:
    AYGTYTGSCG | HVMHAVCWQK | YFEAVQLSSQ | QRIHVDLFDL | ESGEYLCPLC | 
    1250:
    KSLCNTVIPI | IPLQPQKINS | ENADALAQLL | TLARWIQTVL | ARISGYNIRH | 
    1300:
    AKGENPIPIF | FNQGMGDSTL | EFHSILSFGV | ESSIKYSNSI | KEMVILFATT | 
    1350:
    IYRIGLKVPP | DERDPRVPML | TWSTCAFTIQ | AIENLLGDEG | KPLFGALQNR | 
    1400:
    QHNGLKALMQ | FAVAQRITCP | QVLIQKHLVR | LLSVVLPNIK | SEDTPCLLSI | 
    1450:
    DLFHVLVGAV | LAFPSLYWDD | PVDLQPSSVS | SSYNHLYLFH | LITMAHMLQI | 
    1500:
    LLTVDTGLPL | AQVQEDSEEA | HSASSFFAEI | SQYTSGSIGC | DIPGWYLWVS | 
    1550:
    LKNGITPYLR | CAALFFHYLL | GVTPPEELHT | NSAEGEYSAL | CSYLSLPTNL | 
    1600:
    FLLFQEYWDT | VRPLLQRWCA | DPALLNCLKQ | KNTVVRYPRK | RNSLIELPDD | 
    1650:
    YSCLLNQASH | FRCPRSADDE | RKHPVLCLFC | GAILCSQNIC | CQEIVNGEEV | 
    1700:
    GACIFHALHC | GAGVCIFLKI | RECRVVLVEG | KARGCAYPAP | YLDEYGETDP | 
    1749:
    GLKRGNPLHL | SRERYRKLHL | VWQQHCIIEE | IARSQETNQM | LFGFNWQLL
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    String:
    UniGene:
    SMR:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    E2362h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    E2362m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    U2362m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    U2362h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    P2362Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human E3 ubiquitin-protein ligase UBR1
    Cat.:
    P2362Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human E3 ubiquitin-protein ligase UBR1
    Monoclonal Antibody for Human E3 ubiquitin-protein ligase UBR1
    Protein for Human E3 ubiquitin-protein ligase UBR1
    Protein for Human E3 ubiquitin-protein ligase UBR1

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia."
      Kwak K.S. , Zhou X. , Solomon V. , Baracos V.E. , Davis J. , Bannon A.W. , Boyle W.J. , Lacey D.L. , Han H.Q.
      Cancer Res.64:8193-8198(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);TISSUE SPECIFICITY;FUNCTION
    2. 2.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)
      tissue: Brain.
    3. 3.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 18-1727 (ISOFORM 1)
      tissue: Erythroid cell.
    4. 4.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 166-1014 (ISOFORM 1)
      tissue: Placenta.
    5. 5.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 656-1749 (ISOFORM 2)
      tissue: Heart.
    6. 6.
      "The mouse and human genes encoding the recognition component of the N-end rule pathway."
      Kwon Y.T. , Reiss Y. , Fried V.A. , Hershko A. , Yoon J.K. , Gonda D.K. , Sangan P. , Copeland N.G. , Jenkins N.A. , Varshavsky A.
      Proc. Natl. Acad. Sci. U.S.A.95:7898-7903(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 702-1034 (ISOFORM 1);TISSUE SPECIFICITY
    7. 7.
      "RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway."
      Yin J. , Kwon Y.T. , Varshavsky A. , Wang W.
      Hum. Mol. Genet.13:2421-2430(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH RECQL4;IDENTIFICATION BY MASS SPECTROMETRY
    8. 8.
      "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
      Matsuoka S. , Ballif B.A. , Smogorzewska A. , McDonald E.R. III , Hurov K.E. , Luo J. , Bakalarski C.E. , Zhao Z. , Solimini N. , Lerenthal Y. , Shiloh Y. , Gygi S.P. , Elledge S.J.
      Science316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1179;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Embryonic kidney.
    9. 9.
      "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
      Daub H. , Olsen J.V. , Bairlein M. , Gnad F. , Oppermann F.S. , Korner R. , Greff Z. , Keri G. , Stemmann O. , Mann M.
      Mol. Cell31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    10. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2;PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS];CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]
    11. 11.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    12. 12.
      "Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway."
      Kume K. , Iizumi Y. , Shimada M. , Ito Y. , Kishi T. , Yamaguchi Y. , Handa H.
      Genes Cells15:339-349(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    13. 13.
      "Structural basis of substrate recognition and specificity in the N-end rule pathway."
      Matta-Camacho E. , Kozlov G. , Li F.F. , Gehring K.
      Nat. Struct. Mol. Biol.17:1182-1187(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 98-167 ALONE AND IN COMPLEX WITH N-END RULE PEPTIDE;UBR-TYPE ZINC-FINGER;FUNCTION;VARIANT JB5 ARG-136
    14. 14.
      "Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome)."
      Zenker M. , Mayerle J. , Lerch M.M. , Tagariello A. , Zerres K. , Durie P.R. , Beier M. , Hulskamp G. , Guzman C. , Rehder H. , Beemer F.A. , Hamel B.C.J. , Vanlieferinghen P. , Gershoni-Baruch R. , Vieira M.W. , Dumic M. , Auslender R. , Gil-da-Silva-Lopes V.L. , more...
      Nat. Genet.37:1345-1350(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS JBS ARG-136 AND SER-1279;FUNCTION;DISEASE;TISSUE SPECIFICITY;SUBCELLULAR LOCATION;DEVELOPMENTAL STAGE
    Product Feedback Wall
    Hot Genes
    Top Searches
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter